| Literature DB >> 35725379 |
Zi Xiang Lim1,2,3, Jorming Goh4,5,6.
Abstract
BACKGROUND: Aging leads to a number of structural and physiological deficits such as loss of muscle mass and strength. Strength training at ~ 70% of 1 repetition max (RM) is recommended to prevent age-related loss of muscle mass and strength. However, most older adults may not be able to perform 70% of 1RM or higher intensity. An alternative exercise training program combining low intensity resistance exercise with blood flow restriction (BFR) can result in similar acute and chronic benefits to skeletal muscles in older adults. MAIN BODY AND SHORTEntities:
Keywords: Hyperaemic reperfusion; Hypoxia; Low intensity exercise; Sarcopenia; Skeletal muscle hypertrophy
Year: 2022 PMID: 35725379 PMCID: PMC9208167 DOI: 10.1186/s11556-022-00294-0
Source DB: PubMed Journal: Eur Rev Aging Phys Act ISSN: 1813-7253 Impact factor: 6.650
Fig. 1AKT-mTOR signalling pathways in skeletal muscle for protein synthesis. Red “+” sign indicates hyperphosphorylation of protein at baseline with aging. 4E-BP1: 4E binding protein 1; AKT: protein kinase B; eEF2: Eukaryotic elongation factor 2; eIF2Bε: eukaryotic translation initiation factor 4E; ERK/MAPK: extra-cellular signal-regulated kinase; IGF-I: insulin-like growth factor 1; IRS: insulin receptor substrate; MnK1: mitogen-activated protein kinase-interacting kinase 1; mTORC1/2: mammalian target of rapamycin complex 1/2; PI3K: phosphatidylinositol-3 kinase; PIP3: phosphatidylinositol-3,4,5-triphosphate; REDD1: regulated in development and DNA damage responses 1; Rheb: ras-homolog enriched in brain; rpS6: ribosomal protein S6 (S6); S6K1; ribosomal protein S6 kinase beta-1 (p70S6 kinase 1); TSC: tuberous sclerosis complex
Acute resistance exercise with BFR in older adults
| Article | Subject characteristics | Exercise protocol | BFR method | Side effects | Research outcomes |
|---|---|---|---|---|---|
| [ | 14♀, (45 ± 9.9 yo) Hypertensive & sedentary | 30% 1RM, bilateral knee extension 3 × 15 reps 45 sec rest between sets | 80% of arterial pressure occlusion | Not mentioned | SBP up to 60 min post-exercise 13.2% HR DBP |
| [ | 7♂, (70 ± 2 yo) Healthy, nonclinical Physically active but no structured training | 20% 1RM, bilateral knee extension 30, 15,15, 15 reps 30 sec rest between sets | 200 mmHg | Reported discomfort comparable to high-intensity resistance exercise. No side effects reported up to 1-week post-exercise | Leg circumference 52% Blood lactate 175% Cortisol ~ 1100% GH ~ 400% IL-6 IGF-I D-dimer Blood glucose Muscle protein synthesis ~ 50% mTOR Ser2448 ~ 30% S6K1 Thr389 ~ 300% S6 Ser235/235 ~ 1000% S6 Ser 240/244 ~ 500% MnK1 Thr197/202 ~ 200% AKT Thr308 ~ 72% 4E-BP1, eEF2, eIF2Bε REDD1 gene expression 41% REDD2 gene expression 42% REDD1 protein AMPKα Thr172 HSP70 FAK Tyr576/577 FOXO3a Ser253 |
| [ | 7♂, (71.0 ± 6.5 yo) Healthy, nonclinical Performs regular aerobic exercise, but not resistance exercise | 20% 1RM, unilateral knee extension 5 sets (30, 9, 6, 5, 4 reps) 30 sec rest between sets | ~ 110 mmHg | Not mentioned | GH ~ 220% Vascular endothelial growth factor ~ 250% IL-6 ~ 15% Cortisol IGF-1 |
| [ | 18♀, (67.0 ± 1.7 yo) Hypertensive & sedentary | 20% 1RM, bilateral knee extension 3 × 10 reps 1 min rest between sets | 80% of arterial pressure occlusion | Not mentioned | SBP ~ 60.0% DBP ~ 62.6% HR ~ 22.1% SVR ~ 66.5% SV CO SBP ~ 2.2% DBP ~ 2.4% HR ~ 8.1% SVR SV ~ 30.7% CO ~ 27.9% Lactate ~ 28.6% |
| [ | 12♀, (57 ± 7 yo) Hypertensive & sedentary | 20% 1RM, leg press 3 × 15 reps 30 sec rest between sets | 100% of arterial pressure occlusion | Not mentioned | SBP ~ 62.2% DBP ~ 69.6% HR ~ 58.3% CO ~ 20% SVR only in 2nd & 3rd set ~ 42.0% SBP ~ 35.9% DBP ~ 15.1% HR ~ 14.5% CO ~ 17.8% SVR ~ 54.6% |
| [ | 13♂, (70 ± 5 yo) Healthy, nonclinical & sedentary | 20% 1RM, leg press 30, 15, 15, 15 reps 1 min rest between sets 2 sec concentric, 2 sec eccentric | 60% of arterial pressure occlusion | Not mentioned | MAP & SBP Lactate |
↑Indicates significantly increased
↓Indicates significantly decreased
↔Indicates no significant difference
4E-BP1: 4E binding protein 1; AKT: protein kinase B; AMPKα: 5′ adenosine monophosphate-activated protein kinase; eEF2: Eukaryotic elongation factor 2; eIF2Bε: eukaryotic translation initiation factor 4E; ERK/MAPK: extra-cellular signal-regulated kinase; FAK: Focal adhesion kinase; FOXO3a: Forkhead box transcription factors; HSP70: Heat stress protein 70; IGF-I: insulin-like growth factor 1; IRS: insulin receptor substrate; MnK1: mitogen-activated protein kinase-interacting kinase 1; mTORC1/2: mammalian target of rapamycin complex 1/2; PI3K: phosphatidylinositol-3 kinase; PIP3: phosphatidylinositol-3,4,5-triphosphate; REDD1: regulated in development and DNA damage responses 1; Rheb: ras-homolog enriched in brain; rpS6: ribosomal protein S6 (S6); S6K1; ribosomal protein S6 kinase beta-1 (p70S6 kinase 1); TSC: tuberous sclerosis complex; CO: Cardiac output; DBP: diastolic blood pressure; GH: growth hormone; HR: heart rate; IL-6: interleukin-6; MAP: mean arterial pressure SBP: systolic blood pressure; SV: stroke volume; SVR: systemic vascular resistance
Resistance training with BFR in older adults
| Article | Subject characteristics | Exercise Frequency | Rest duration | Exercise Intensity | Number of sets x reps | Blood flow restriction method | Side effects | Research outcomes |
|---|---|---|---|---|---|---|---|---|
| [ | 8♀, (63.8 ± 11.6 yo) Hypertensive & sedentary | 8 weeks, 2 x/ week Wrist flexion 1.5 sec concentric, 1.5 sec eccentric | 30 sec between sets | 30% 1RM | 3 sets 12, 10, 8 reps | 70% of arterial pressure occlusion | Not mentioned | SBP 11.0% DBP 12.1% MAP 11.6% HR, Cortisol and IL-6 |
| [ | Mixed (5♂, 7♀), (76.5 (72.3–80.7) yo) Healthy, nonclinical & sedentary | 12 weeks, 2 x/ week Leg curl Leg extension 3 sec concentric, 3 sec eccentric | 60 sec rest between sets 3 min rest between exercises | 30% 1RM Leg press 50% 1RM | 1st week 1 set to failure 2nd week 2 sets to failure 3rd week onwards 3 sets to failure | 150% of arterial pressure occlusion | Not mentioned | Quadriceps CSA 4.3% Leg extension strength (1RM) 24% Leg press strength (1RM) 12% Walking speed 4% Short Physical Performance Battery, Quality of life Leg curl strength (1RM) |
| [ | Mixed (5♂, 6 ♀), (63.3 ± 4.1 yo) Healthy, nonclinical & sedentary | 12 weeks, 4 x/ week i) 2 days Endurance training (ET) ii) 2 days low-intensity resistance exercise with BFR | Not mentioned | 1st 6 weeks 20% 1RM 7th week onwards 30% 1RM | 1 set × 30 reps 3 sets × 15 reps | 50% of arterial pressure occlusion | Not mentioned | Quadriceps CSA 7.3% Leg press strength (1RM) 35.4% V̇O2peak 10.3% C reactive protein IL-6 25% IL-10 |
| [ | Mixed (6♂,10♀), (67.2 ± 5.2 yo) Healthy, non-clinical & sedentary | 12 weeks, 3 x/ week Leg press Leg extension Leg curl Calf flexion | Not mentioned | 20% 1RM | To failure | Equation (pressure mm Hg = 0.5 (SBP) + 2 (thigh circumference) + 5) | 21 were deemed related or possibly related to the study (6 BFR; 15 moderate intensity resistance training (MIRT)) The majority of these were related to knee pain ( | Knee extensor strength ~ + 18.1% Gait speed + 8.6% Short physical performance battery ~ + 0.1% Lean mass ~ + 0.5% |
| [ | 13♂, (55.9 ± 1.0 yo) Healthy, nonclinical & recreationally active | 6 weeks 3 x/ week Leg extension for three sets | 1 min rest between sets, 5–10 min rest between exercises | 20% 1RM | 30, 15, 15 reps | Start with 160 mmHg, Increase by 20 mmHg if rate of perceived exertion (RPE) was lower than 16 | Not mentioned | Lat pulldown ~ 15.9% Shoulder press ~ 9.6% Bicep curl ~ 19.3% Leg press 19.3% Leg extension 19.1% |
| [ | Mixed ( Healthy, nonclinical & sedentary | 12 weeks, 4x/ week i) BFR 2 x/ week Leg press ii) ET 2 x/ week: walk/run 30–40 min, 50–80% V̇O2peak | 60 sec rest between sets | 1st 6 weeks 20% 1RM 30% 1RM for next 6 weeks | 30, 15, 15, 15 reps | 50% of arterial pressure occlusion | Not mentioned | Quadricep CSA 7.6% Leg press (1RM) 35.4% V̇O2peak 10.3% |
| [ | Case study (n = 1, ♂, 91 yo) Hypertensive Sarcopenic Cardiovascular disease Sedentary | 8 weeks, 3 x/ week Treadmill walking, 30% heart rate reserve Elbow flexion Elbow extension Leg press Leg extension | 1 min rest between sets and exercises | 30% 1RM | 3 sets of 10 RM. No report on the number of reps. | 50% of arterial pressure occlusion | No clinical interference during exercise. No reports of discomfort or pain during low-intensity BFR | Lean mass − 3.6% Hand grip + 17.9% Peak torque extension + 4.6% Total work + 1.5% Work fatigue + 27.5% |
| [ | Mixed (8♂, 2♀), (67 ± 3 yo) Healthy, nonclinical, physically active but not resistance-trained | 4 weeks 3 x/ week Plantar flexion with one leg BFR; Control leg without BFR on same person | 1 min rest between sets 3 min rest legs | 25% 1RM | 3 sets Exercise to failure in BFR limb Control limb follows similar reps | 110 mmHg | 100% free of injury or complications | Calf girth ~ 1.17% SBP DBP 1RM ~ 13.5% MVC ~ 17.6% 0.52 N/m ~ 15.7% 1.05 N/m 2.09 N/m Resting limb blood flow Blood flow after 5 min circulatory occlusion ~ 38.9% |
| [ | 10♀, (64 ± 4 yo) Healthy, nonclinical & sedentary | 12 weeks, 4 x/ week i) 2 days Resistance training: Leg press ii) 2 days ET 50–80% V̇O2peak, 30–40 min | 60 sec rest between sets | 1st 6 weeks 20% 1RM 2nd 6 weeks 30% 1RM | 30, 15, 15, 15 reps | 50% of arterial pressure occlusion | Not mentioned | V̇O2peak ~ 10.3% Leg press (1RM) ~ 35.4% Quadriceps CSA ~ 7.6% |
| [ | Mixed (16♂, 4♀), (72 ± 4 yo) Healthy, nonclinical & sedentary | 4 weeks, 3 x/ week Leg extension Leg press Rowing Chest press | 30 sec between sets | 20% 1RM | 3 × 20 reps | 100% of arterial pressure occlusion | Not mentioned | HR 33.8% SBP ~ 38.4% DBP ~ 45.2% Lactate ~ 500% NE ~ 55.0% VEGF ~ 42.3% GH ~ 244.0% EPI RHI ~ 16.7% vWF ~ 4% TM tcPO2 ~ 16.7% Muscle strength- leg extension (1RM) ~ 19.0% Muscle strength- leg press (1RM) ~ 11.3% Muscle strength- rowing (1RM) ~ 9.18% Muscle strength chest press (1RM) |
| [ | Mixed (3♂, 2♀), (59 ± 2 yo) Postmenopausal, healthy & recreationally active | 30 sec between sets 30–120 sec between exercises | Resistance band estimated ~ 10–30% 1RM | 30, 15, 15 reps | Upper body exercise with BFR 120 mmHg Lower body without BFR | Not mentioned | Chest press strength ~ 8.0% Seated row ~ 5.4% Shoulder press ~ 5.0% Leg press ~ 7.6% Right hip extension ~ 9.7% Left hip extension ~ 8.9% Right hip flexion ~ 27.3% Left hip flexion ~ 39.6% Right knee extension ~ 12.8% Left knee extension ~ 7.9% Right knee flexion ~ 22.1% Left knee flexion ~ 12.8% Muscle thickness pectoralis major 17.4% Other muscle thickness | |
| [ | Mixed ( (65.0 ± 2.0 yo) Healthy, nonclinical & sedentary | 12 weeks, 2 x/ week Leg press 2 sec concentric, 2 sec eccentric | 1 min rest between sets | 1st 6 weeks 20% 1RM 30% 1RM for following weeks | 30, 15, 15, and 15 reps | 50% of arterial pressure occlusion | Not mentioned | Leg press (1RM) Muscle CSA quadriceps ~ 5.93% |
| [ | Mixed (3♂, 2♀), (64 ± 3 yo) Healthy, nonclinical & physically active | 12 weeks, 2 x/ week Leg press | 1 min rest between sets | 1st 6 weeks 20% 1RM 2nd 6 weeks 30% 1RM | 30, 15, 15, 15 reps | 50% of arterial pressure occlusion | Not mentioned | Leg press (1 RM) #
Muscle CSA quadriceps #
# The magnitude of increase in strength and size were not provided Enriched 159 gene ontology pathways as compared to control Enriched 2 gene ontology pathways as compared to HI |
| [ | Mixed (3♂, 6♀), (71.3 ± 7.1 yo) Healthy, nonclinical & sedentary | 12 weeks, 2 x/ week Leg press 1.3 sec concentric, 1.3 sec eccentric Knee extension 1.0 sec concentric, 1.0 sec eccentric | 30 sec rest between sets 90 sec rest between exercises | 20–30% 1RM | 30, 20, 15, and 10 reps | full- first day set 120 mmHg, subsequently increase 10-20 mmHg until 270 mmHg | Not mentioned | Muscle CSA quadriceps 8.0% Muscle CSA adductors 6.5% Muscle CSA gluteus maximus 4.4% Leg extension (1RM) 26.1% Leg press (1RM) 33.4% Chair stand test (reps) 18.3% HR, blood pressure, FMD, CAVI, ABI, FDP, D-dimer, CK |
| [ | Mixed (2♂, 7 ♀), (71.8 ± 6.2 yo) Healthy, nonclinical & sedentary | 12 weeks, 2 x/ week Bilateral arm curl Triceps press down 1.2 sec concentric, 1.2 sec eccentric | 30 sec rest between sets 90 sec rest between exercises | “Heavy (Green)” resistance band for men “Thin (Yellow)” resistance band for women | 30, 15, 15, 15 reps | full- first day set 120 mmHg, subsequently increase 10-20 mmHg until 270 mmHg | Not mentioned | Muscle thickness elbow flexor ~ 17.6% Muscle thickness elbow extensor ~ 17.4% Muscle strength elbow flexor MVC ~ 7.8% Muscle strength elbow extensor MVC ~ 16.1% HR, blood pressure, CAVI, ABI |
| [ | 10♀, (70 ± 6 yo) Healthy, nonclinical & physically active but not resistance trained | 12 weeks, 2 x/ week Squat 1.3 sec concentric, 1.3 sec eccentric Knee extension 1.0 sec concentric, 1.0 sec eccentric | 30 sec rest between sets 90 sec rest between exercises | One gold resistance band for squat One black resistance band for knee extension Considered low-intensity bands as compared with bands used in HI protocol in the same study. | 30, 15, 15, 15 reps | full- first day set 120 mmHg, subsequently increase 10–20 until 200 mmHg | Not mentioned | Anterior mid-thigh 10.6% Quadricep CSA 6.9% Knee extension (MVC) 13.7% Leg press (1RM) 16.4% Knee extension (1RM) c-SBP, c-Aix, CAVI, and ABI |
| [ | Mixed (11♂, 5 ♀), (55 ± 7 yo) Healthy, nonclinical & sedentary | 6 weeks, 3 x/ week Lateral knee extension one limb with BFR one limb without BFR 1.5 sec concentric, 1.5 sec eccentric | 1 min rest between sets | 30% 1RM | Volitional fatigue | 1st week 150 mmHg or 50% of arterial occlusion pressure (whichever was lower) 2nd week onwards 80% arterial occlusion pressure but no higher than 240 mmHg | Not mentioned | Knee extension 1RM ~ 10.9% Anterior thigh muscle thickness ~ 5.1% Lateral thigh muscle thickness ~ 4.0% Pulse wave velocity ~ 6.7% Cardiovascular vascular conductance |
| [ | 16 ♀, (64.7 ± 3.7 yo) Healthy, nonclinical & sedentary | 14 weeks, 2 x/ week Wrist flexion 1.5 sec concentric, 1.5 sec eccentric | 40 sec rest between sets | 40% 1RM | 3 × 15 reps | 70% of arterial pressure occlusion | Not mentioned | Wrist flexion strength (1RM) 55.3% Quality of life Chair stand test |
↑ Indicates significantly increased
↓ Indicates significantly decreased
↔ Indicates no significant difference
# Indicates result details not provided in article
- Indicates decrease, without statistical analysis as they are case studies/case series
+ Indicates increase, without statistical analysis as they are case studies/case series
1RM: 1 repetition maximal; ABI: ankle-brachial pressure Index; c-Aix: central-augmented Index; c-SBP: central systolic blood pressure; CAVI: cardio-ankle vascular index; CK: creatine kinase; CSA: cross sectional area; DBP: diastolic blood pressure; EPI: epinephrine; FDP: fibrinogen degradation products; FMD; flow mediated dialation; GH: growth hormone; HR: heart rate; IL-6/10: interleukin-6/10; MAP: mean arterial pressure; NE: norepinephrine; RHI: reactive hyperaemia index; SBP: systolic blood pressure; SV: stroke volume; SVR: systemic vascular resistance; tcPO2: transcutaneous oxygen pressure; TM: thrombomodulin; TPR: total peripheral resistance; VEGF: vascular endothelial growth factor; V̇O2peak: peak volume of oxygen consumed per min vWF: von Willebrand factor